NEW YORK (GenomeWeb) – GenomeDx Biosciences has inked a research collaboration with Astellas to investigate use of its Decipher Classifier and Genomics Resource Information Database (GRID) to assess prostate cancer tumor aggressiveness and treatment response.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.